4.7 Article

Does co-treatment with immunosuppressors improve outcome in patients with Crohn's disease treated with adalimumab?

Related references

Note: Only part of the references are listed.
Review Gastroenterology & Hepatology

The Natural History of Adult Crohn's Disease in Population-Based Cohorts

Laurent Peyrin-Biroulet et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)

Article Gastroenterology & Hepatology

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis

Gert Van Assche et al.

JOURNAL OF CROHNS & COLITIS (2010)

Article Medicine, General & Internal

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease.

Jean Frederic Colombel et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Gastroenterology & Hepatology

Influence of Trough Serum Levels and Immunogenicity on Long-term Outcome of Adalimumab Therapy in Crohn's Disease

Konstantinos Karmiris et al.

GASTROENTEROLOGY (2009)

Article Gastroenterology & Hepatology

Adalimumab Safety in Global Clinical Trials of Patients with Crohn's Disease

Jean-Frederic Colombel et al.

INFLAMMATORY BOWEL DISEASES (2009)

Article Medicine, General & Internal

Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease

F Baert et al.

NEW ENGLAND JOURNAL OF MEDICINE (2003)